CLOPIXOL DEPOT 500MG/ML DIN 02230407
Status: Approved
Holder: LUNDBECK CANADA INC
Health Canada record
| Active ingredient(s) | ZUCLOPENTHIXOL DECANOATE 500 MG |
|---|
| Dosage form | Liquid |
|---|
| Route | Intramuscular |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Human |
|---|
| ATC | N05AF05 ZUCLOPENTHIXOL |
|---|
| Original market date | |
|---|
| Current status date | 30-Jan-1997 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Lundbeck Canada Inc — licence 100814, currently licensed, last inspection rating C (2023-04-11).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ZUCLOPENTHIXOL DECANOATE
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02230406 | CLOPIXOL DEPOT | LUNDBECK CANADA INC | Solution | ZUCLOPENTHIXOL DECANOATE 200 MG | Marketed |
| 02162954 | CLOPIXOL DEPOT - LIQ IM 200MG/ML | HOECHST MARION ROUSSEL CANADA INC. | Liquid | ZUCLOPENTHIXOL DECANOATE 200 MG | Cancelled Post Market |
| 02162962 | CLOPIXOL DEPOT - LIQ IM 500MG/ML | HOECHST MARION ROUSSEL CANADA INC. | Liquid | ZUCLOPENTHIXOL DECANOATE 500 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 4102 | 1997-01-30 | New Drug Submission (NDS) | |
Request a quote for CLOPIXOL DEPOT 500MG/ML
How to read a Canadian DIN record